Mangalam Organics Secures INR 60 Crore Through Private Placement of NCDs Aug 18, 2025
More news about Mangalam Organics
09Aug 25
Mangalam Organics Reports Strong Q1 Results with 632% PAT Growth
Mangalam Organics, a leading manufacturer of terpene and rosin derivatives, reported robust Q1 FY24 results. Revenue increased by 24.2% to ₹146.55 crores, EBITDA nearly doubled to ₹21.6 crores, and PAT surged by 632.30% to ₹12.23 crores. The company's performance was driven by decreased input costs, improved operational efficiency, and strong market demand. Mangalam Organics operates in B2B (96% of revenue) and B2C segments, focusing on terpene products, synthetic resins, and homecare products. The company is pursuing strategic initiatives including product portfolio expansion, geographical reach extension, e-commerce focus, and exploring new export opportunities in the USA and UK.
Mangalam Organics Limited reported robust Q1 financial results with revenue from operations increasing by 24.2% year-over-year to ₹14,655.39 lakhs. Profit before tax grew by over 600% to ₹1,468.70 lakhs. The company scheduled its 43rd AGM for September 16 and announced re-appointment of key directors. New auditor appointments were made, including Internal Auditor, Cost Auditor, and Secretarial Auditor. The company also approved amendments to its Insider Trading Policy. A fire incident occurred at the Camphor Plant on July 16, but the company is working to augment production through Camphor Plant-II.